Cardiovascular risk in women with type 2 diabetes

Medical Clinics of North America

Volumn 87, Issue 5, 2003, Pages 955-969

  Brandenburg, Suzanne L ^a   Lindenfeld, JoAnn ^a   Reusch, Jane E B ^a   Regensteiner, Judith G ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EXERCISE TOLERANCE; FEMALE; FIBRINOLYSIS; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; WEIGHT REDUCTION;

EID: 0242364623     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00113-5     Document Type: Review

References (72)

1. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 2000;16:230-6.
2. American Diabetes Association. Diabetes 1996 vital statistics. In: Cowie CC, Eberhardt MS, editors. Alexandria (VA): American Diabetes Association; 1996. p. 1.
3. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US Diabetes Care. 2001;24:1936-40.
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
5. Thomas RJ, Palumbo PJ, Melton LJ 3rd, Roger VL, Ransom J, O'Brien PC, et al. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn. Arch Intern Med 2003;163:445-51.
6. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002;162:1737-45.
7. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627-31.
8. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61.
9. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986;123:504-16.
10. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. Guide to preventive cardiology for women. AHA/ACC Scientific Statement Consensus panel statement. Circulation 1999;99:2480-4.
11. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8-13.
12. Abbott RD, Donahue RP, Kannel WB, Wilson PWF. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA 1988;260:3456-60.
13. Heyden S, Heiss G, Bartel AG, Hames CG. Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chronic Dis 1980;33:265-73.
14. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.
15. Vittinghoff E, Shlipak MG, Varosy PD, Furberg CD, Ireland CC, Khan SS, et al. Risk factors and secondary prevention in women with heart disease: The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2003;138:81-9.
16. Miller AP, Oparil S. Secondary prevention of coronary heart disease in women: a call to action. Ann Intern Med 2003;138:150-1.
17. Liao Y, Cooper RS, Ghali JK, Lansky D, Cao G, Lee J. Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease. Diabetes Care 1993;16:708-13.
18. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. Arch Intern Med 2001;161:1717-23.
19. Goldschmid MG, Barrett-Connor F, Edelstein SL, Wingard DL, Cohn BA, Herman WH. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 1994;89:991-7.
20. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:1-9.
21. Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: the Northern California Kaiser Permanente Diabetes Registry. Diabetes Care 2001;24:1144-50.
22. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann Intern Med 1977;87:393-7.
23. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E Jr. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984;311:953-9.
24. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998;21:1258-65.
25. UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 1994; 11:534-44.
26. Haffner SM, Mykkanen L, Stern MP, Paidi M, Howard BV. Greater effect of diabetes on LDL size in women than in men. Diabetes Care 1994;17:1164-71.
27. Shaefer EJ, McNamara JR, Shah PK, Nakajima K, Cupples LA, Ordovas JM, et al. Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. Diabetes Care 2002;25(6):989-94.
28. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
29. Sacks FM, Pfeffer MA, Moye LLA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9.
30. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998; 1349-57.
31. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1998;97:1440-5.
32. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. For the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22.
33. MRC/BHF heart protection study of cholesterol lowering with simrastatin in 20, 536 high risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
34. MRC/BHF heart protection study of cholesterol lowering with simuastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-16.
35. Haffner SM, Valdez R, Morales PA, Mitchell BD, Hazuda HP, Stern MP. Greater effect of glycemia on incidence of hypertension in women than in men. Diabetes Care 1992;15: 1277-84.
36. Suarez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 1984; 120:670-5.
37. Al-Delaimy WK, Willett WC, Manson JE, Speizer FE, Hu FB. Smoking and mortality among women with type 2 diabetes: the Nurses' Health Study cohort. Diabetes Care 2001;24:2043-8.
38. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987;317:1303-9.
39. Al-Delaimy WK, Manson JE, Solomon CG, Kawachi I, Stampfer MJ, Willett WC, et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002;162:273-9.
40. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-10.
41. Cho E, Manson JE, Stampfer MJ, Solomon CG, Colditz GA, Speizer F, et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care 2002;25:1142-8.
42. Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB, et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 2000;102:494-9.
43. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994;43:104-9.
44. Donders SH, Lustermans FA, van Wersch JW. Low order correlations of lipoprotein (a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients. Blood Coagul Fibrinolysis 1992;3:249-56.
45. Cho YW, Oh DY, Kim SJ, Hong SY, Lee HC, Huh KB. Euglobulin fibrinolytic activity in NIDDM patients. Diabetes Res Clin Pract 1991;13:139-45.
46. Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995;91:1952-8.
47. Testa R, Bonfigli AR, Piantanelli L, Manfrini S, Testa I, Gregorio F. Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996;33:111-8.
48. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 1997;40:843-9.
49. Brandenburg SL, Reusch JE, Felder KK, Nelson-Wong E, Lindenfeld J, Manco-Johnson M, et al. Impaired fibrinolysis in premenopausal women with type 2 diabetes mellitus (DM). J Investig Med. 2002;50:110-5.
50. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
51. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002;25:2016-21.
52. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-7.
53. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22:1668-73.
54. Garcia-Moll X, Zouridakis E, Cole D, Kaski JC. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. The European Society of Cardiology 2000;21:1598-606.
55. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, et al. Type II diabetes abrogates sex differences in endothelial function in premonopausal women. Circulation 2000;101:2040-6.
56. Kingwell BA, Medley TL, Waddell TK, Cole TJ, Dart AM, Jennings GL. Large artery stiffness: structural and genetic aspects. Clin Exp Pharmacol Physiol 2001;28:1040-3.
57. Jensen-Urstad K, Johansson J. Gender difference in age-related changes in vascular function. J Intern Med 2001;250:29-36.
58. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-75.
59. Gill EA, Weil JV, Popylisen S, Pickett C, Reusch JEB, Wolfel EE, et al. Administration of L-arginine or antioxidant vitamins increases endothelial dilator function in women with type 2 diabetes mellitus. Circulation 1999;100(Suppl 1):I757.
60. Ford ES, DiStefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up study. Am J Epidemiol 1991; 133:1220-30.
61. Hu FB, Stampfer JM, Solomon C, Liu S, Colditz GA, Speizer FE, et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 2001;134:96-105.
62. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003;289:1785-91.
63. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995;27:875-81.
64. Schneider SH, Amorosa LF, Khachadurian AK and Ruderman NB. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia 1984;26:355-60.
65. Kjaer M, Hollenbeck CB, Frey-Hewitt B, Galbo H, Haskell W, Reaven GM. Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes. J Appl Physiol 1990;68:2067-74.
66. Regensteiner JG, Bauer TA, Reusch JEB, Brandenburg SL, Sippel JM, Vogelsong AM, et al. Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol 1998;85:310-7.
67. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 2000;132:605-11.
68. Karlefors T. Haemodynamic studies in male diabetics. Acta Med Scand Suppl 1996;449:45-80.
69. Roy TM, Peterson HR, Snider HL, Cyrus J, Broadstone VL, Fell RD, et al. Autonomic influence on cardiovascular performance in diabetic subjects. Am J Med 1989;87:382-8.
70. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977;60:884-99.
71. Regensteiner JG, Groves BM, Bauer TA, Reusch JEB, Smith SC, Wolfel EE. Recently diagnosed type 2 diabetes mellitus adversely affects cardiac function during exercise. Diabetes 2002;51(Suppl 2):A59.
72. Haffner SM, Miettinen H, Stern MP. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia 1997;40:711-7.